ARDS and septic shock are the main symptoms of severe COVID-19 patients, and are the leading causes of death.50,51 In particular, we monitored high levels of activation of the selected treatment targets, SREBP-2 and NF-κB (Fig. 1). The gene discussed is SREBF2; the disease is acute respiratory distress syndrome.